Multi-center, randomized, double-blind, placebo-controlled study to evaluate the effect of single oral tolvaptan tablets on hemodynamic parameters in subjects with heart failure
Phase of Trial: Phase II
Latest Information Update: 02 May 2012
At a glance
- Drugs Tolvaptan (Primary)
- Indications Heart failure
- Focus Pharmacodynamics; Therapeutic Use
- Acronyms ECLIPSE
- 02 May 2012 Additional lead trial centre and investigator (James Udelson) identified as reported by ClinicalTrials.gov.
- 02 May 2012 Actual end date (Dec 2006) added as reported by ClinicalTrials.gov.
- 30 Oct 2005 New trial record.